OR2AG2 (o2ag2_human)
FAMILY
Class O2 (tetrapod specific odorant) Odorant receptors Odorant family 2 OR2AG2
GENE
OR2AG2 (OR2AG2P)
ORGANISM
Human (Homo sapiens)
ALT. NAMES
Olfactory receptor 2AG2
SOURCE
SWISSPROT
SEQUENCE
N-term | |||||||||
M
|
E
|
L
|
R
|
N
|
S
|
T
|
L
|
G
|
S
|
10 |
G
|
F
|
I
|
L
|
V
|
G
|
I
|
L
|
N
|
D
|
20 |
TM1 | |||||||||
S
|
G
|
S
|
P
|
E
|
L
|
L
|
Y
|
A
|
T
|
30 |
F
|
T
|
I
|
L
|
Y
|
M
|
L
|
A
|
L
|
T
|
40 |
S
|
N
|
G
|
L
|
L
|
L
|
L
|
A
|
I
|
T
|
50 |
ICL1 | TM2 | ||||||||
I
|
E
|
A
|
R
|
L
|
H
|
M
|
P
|
M
|
Y
|
60 |
L
|
L
|
L
|
G
|
Q
|
L
|
S
|
L
|
M
|
D
|
70 |
L
|
L
|
F
|
T
|
S
|
V
|
V
|
T
|
P
|
K
|
80 |
A
|
L
|
A
|
D
|
F
|
L
|
R
|
R
|
E
|
N
|
90 |
ECL1 | TM3 | ||||||||
T
|
I
|
S
|
F
|
G
|
G
|
C
|
A
|
L
|
Q
|
100 |
M
|
F
|
L
|
A
|
L
|
T
|
M
|
G
|
S
|
A
|
110 |
E
|
D
|
L
|
L
|
L
|
A
|
F
|
M
|
A
|
Y
|
120 |
D
|
R
|
Y
|
V
|
A
|
I
|
C
|
H
|
P
|
L
|
130 |
ICL2 | TM4 | ||||||||
K
|
Y
|
M
|
T
|
L
|
M
|
S
|
P
|
R
|
V
|
140 |
C
|
W
|
I
|
M
|
V
|
A
|
T
|
S
|
W
|
I
|
150 |
L
|
A
|
S
|
L
|
I
|
A
|
I
|
G
|
H
|
T
|
160 |
ECL2 | |||||||||
M
|
Y
|
T
|
M
|
H
|
L
|
P
|
F
|
C
|
V
|
170 |
S
|
W
|
E
|
I
|
R
|
H
|
L
|
L
|
C
|
E
|
180 |
I
|
P
|
P
|
L
|
L
|
K
|
L
|
A
|
C
|
A
|
190 |
TM5 | |||||||||
D
|
T
|
S
|
R
|
Y
|
E
|
L
|
I
|
I
|
Y
|
200 |
V
|
T
|
G
|
V
|
T
|
F
|
L
|
L
|
L
|
P
|
210 |
I
|
S
|
A
|
I
|
V
|
A
|
S
|
Y
|
T
|
L
|
220 |
V
|
L
|
F
|
T
|
V
|
L
|
R
|
M
|
P
|
S
|
230 |
TM6 | |||||||||
N
|
E
|
G
|
R
|
K
|
K
|
A
|
L
|
V
|
T
|
240 |
C
|
S
|
S
|
H
|
L
|
I
|
V
|
V
|
G
|
M
|
250 |
F
|
Y
|
G
|
A
|
A
|
T
|
F
|
M
|
Y
|
V
|
260 |
ECL3 | TM7 | ||||||||
L
|
P
|
S
|
S
|
F
|
H
|
S
|
P
|
K
|
Q
|
270 |
D
|
N
|
I
|
I
|
S
|
V
|
F
|
Y
|
T
|
I
|
280 |
V
|
T
|
P
|
A
|
L
|
N
|
P
|
L
|
I
|
Y
|
290 |
H8 | |||||||||
S
|
L
|
R
|
N
|
K
|
E
|
V
|
M
|
R
|
A
|
300 |
L
|
R
|
R
|
V
|
L
|
G
|
K
|
Y
|
I
|
L
|
310 |
L
|
A
|
H
|
S
|
T
|
L
|
LINKS
DIAGRAMS
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
MUTATIONS
PHYSIOLOGICAL LIGANDS
No physiological ligands available
STRUCTURE MODELS
STRUCTURES
No structures available